As of 2026-09-14, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.27 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.42 CAD, the upside of Oncolytics Biotech Inc is -189.72%.
Based on its market price of 1.42 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 189.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.27 - -1.27 | -1.27 | -189.72% |
| P/E | (0.01) - (0.02) | (0.01) | -100.9% |
| DDM - Stable | (2.35) - (7.59) | (4.97) | -450.0% |
| DDM - Multi | (0.04) - (0.10) | (0.06) | -103.9% |
| Market Cap (mil) | 169.48 |
| Beta | 0.89 |
| Outstanding shares (mil) | 119.35 |
| Enterprise Value (mil) | 166.31 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.31% |
| Cost of Debt | 5.00% |
| WACC | 9.28% |